Denemek ALTIN - Özgür
Indira's India & Modi's Bharat
Business Standard
|July 26, 2025
As Narendra Modi becomes India's second-longest consecutively serving Prime Minister, we look at how he compares with Indira Gandhi across four key dimensions
On the day that Narendra Modi won his third term in June 2024, it was inevitable that this year he would become India's second-longest serving Prime Minister in consecutive terms, surpassing Indira Gandhi (January 24, 1966 to March 24, 1977).
It also became inevitable, therefore, that around this time in 2025, the season of Modi vs Indira comparisons will begin. Let me be the first, or among the first, of the block.
First of all, we need to look at the larger political realities in which each came to power and the challenges to their authority. Then we will assess their record across four dimensions: Politics, strategic and foreign affairs, the economy, and nationalism.
Mrs Gandhi and Mr Modi took over in completely different circumstances. There was a differential in political capital between the two. Mrs Gandhi had not won an election in 1966. She was a convenient compromise after Lal Bahadur Shastri's death.
She didn't help her cause by looking overawed in Parliament early on, and Socialist Ram Manohar Lohia dismissed her as a "goongi gudiya" (a doll who didn't speak). She had also inherited a broken economy. The growth rate in 1965 was (-) 2.6 per cent, in fact. The triple blow of a war, droughts, food shortages and instability and the deaths of two prime ministers in harness within 19 months had weakened India.
The picture for Mr Modi in 2014 was the exact opposite. He won a majority, the first in India after 30 years, and was his party's chosen candidate; the economy was averaging a robust 6.5 per cent growth across the preceding 15 years. His was a peaceful, planned, predictable electoral transition. The degree of difficulty on his first day in power was way lower than Mrs Gandhi's, just as his political capital was enormously higher.
Bu hikaye Business Standard dergisinin July 26, 2025 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Business Standard'den DAHA FAZLA HİKAYE
Business Standard
FD left without a Will? Here's how children, grandchildren can claim money
Fixed deposits (FDs) are a common savings tool across Indian households.
1 min
February 14, 2026
Business Standard
Reliance gets US licence to directly buy Venezuela oil
Private-sector oil refiner Reliance Industries Limited (RIL) last week received a general licence from the United States (US) government to buy Venezuelan oil, an industry executive told Business Standard.
1 mins
February 14, 2026
Business Standard
Torrent Pharma profit rises 26%
Ahmedabad-based Torrent Pharmaceuticals on Friday posted a 26 per cent year-on-year (Y-0-Y) increase in net profit on a consolidated basis for the third quarter of the financial year (Q3FY26) to %635 crore. The revenue from operations also grew 17.6 per cent to %3,303 crore.
1 min
February 14, 2026
Business Standard
Delhi-Dhaka ties may warm up after BNP’s win
But stronger Jamaat a concern
2 mins
February 14, 2026
Business Standard
Friday the 13th caps a week of AI-sparked horror in IT stocks
Top software exporters suffer nearly ₹5 trn mcap loss as rout deepens
2 mins
February 14, 2026
Business Standard
BEE may rationalise technology credits
The Bureau of Energy Efficiency (BEE) is planning to rationalise the list of technologies that carmakers can classify as \"fuel-saving\" to claim \"technology derogation credits\" while calculating the average emission of carbon dioxide in a fleet of vehicles, Business Standard has learnt.
2 mins
February 14, 2026
Business Standard
Leverage, time & the long game
This is the game every nation is now learning to play. Some are finding new allies or seeing value among nations where they'd seen marginal interest. The starkest example is India and Europe
5 mins
February 14, 2026
Business Standard
‘Biopharma Shakti shows India focusing on being biopharma hub’
Fresh from a reduction in debt and a capital raise of $1 billion, Biocon Ltd is sharpening its focus on biosimilars, GLP-1s (glucagon-like peptide-1s), and manufacturing on a global scale. In a video interaction with Sohini Das, Biocon Group Chairperson Kiran Mazumdar-Shaw explains how lower borrowing costs will lift profitability, and why regulatory reform and adopting artificial intelligence (AI) are critical for India to be a biopharma hub. Edited excerpts:
3 mins
February 14, 2026
Business Standard
Munich Conference: German Chancellor calls for reset with US as old global order crumbles
German Chancellor Friedrich Merz on Friday called for a stronger Europe to reset its ties with the United States, wanting Washington to “repair and revive trust” in a dangerous new era of great power politics as the old global order crumbles.
1 mins
February 14, 2026
Business Standard
₹70 lakh for 10 secs: India-Pak clash sends ad rates over the ropes
Days after Pakistan backtracked on its earlier decision to boycott the marquee showdown with India at the ongoing ICC Men's T20 World Cup, the commercial upswing following that clarity is already visible.
2 mins
February 14, 2026
Listen
Translate
Change font size
